Bussum, Netherlands, 15 July 2011: MEDLINE® accepts coverage of two more journals published by Bentham Science Publishers. The titles recently accepted to be indexed are: Current Radiopharmaceuticals and Recent Patents on Endocrine, Metabolic and Immune Drug Discovery .
Current Radiopharmaceuticals publishes original research articles, letters and reviews on all areas of radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications. For details please visit the journal website at http://www.benthamscience.com/crp
Recent Patents on Endocrine, Metabolic and Immune Drug Discovery is the part of the continuing popular series of 'Patent Review titles' published by Bentham Science. The journal publishes peer-reviewed review and research articles on important recent patents on fast emerging therapeutic areas/targets & therapeutic agents related to endocrine, metabolic and immune drug discovery. For details please visit the journal website at http://www.benthamscience.com/emi/
MEDLINE® (Medical Literature Analysis and Retrieval System Online) is the U.S. National Library of Medicine's® (NLM) premier bibliographic database that covers areas of the life sciences, behavioral sciences, chemical sciences, and bioengineering. MEDLINE also covers aspects of biology, environmental science, marine biology, plant and animal science as well as biophysics and chemistry. MEDLINE is the primary component of PubMed®, part of the Entrez series of databases provided by NLM's National Center for Biotechnology Information (NCBI). Publications covered in MEDLINE are mostly scholarly journals, newspapers, magazines, and newsletters considered useful in the field of life sciences. For further information about Medline visit http://www.nlm.nih.gov/pubs/factsheets/medline.html.